Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Vesenbeckh, J. Becker, C. Bürger, N. Schönfeld, T. Blum, T. Bauer (Berlin, Greifswald, Germany). A case of oral desensibilization in recurrent allergic reactions against intravenous paraaminosalicylic acid (PAS). Eur Respir J 2010; 36: Suppl. 54, 3142

Member's Comments

No comment yet.

Related content which might interest you: High-dose inhalation corticosteroids in conjunction with plasmapheresis in the treatment of patients with acute variant of exogenic allergic alveolitis (EAA) Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura Year: 2012 Evaluation of the effect of endrobronchial route administration of tranexamic acid in airway bleeding Source: Annual Congress 2007 - Therapeutic bronchoscopy Year: 2007 Hypersensitivity pneumonitis caused by oral aspirin Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009 Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma Source: International Congress 2017 – Asthma management Year: 2017 The effects of oral corticosteroid treatment (OCS) on sequential lung function tests in a cohort of patients with acute hypersensitivity pneumonitis (AHP) Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children Year: 2020 Complex treatment of allergic bronchopulmonary aspergillosis (ABPA) in asthmatic patient including anti-IgE therapy – A case report Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012 The role of topical nasal steroids (TNS) in the treatment of bronchial asthma (BA) combined with nasal polyposis (NP) Source: Eur Respir J 2004; 24: Suppl. 48, 259s Year: 2004 Effect of antioxidants, L-2-oxothiazolidine-4-carboxylic acid and α-lipoic acid, on airway remodeling in chronic model of allergic airway disease Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 The inhalation provocation test with sodium diclofenac for assessment of aspirin exacerbated respiratory diseases (AERD) Source: Eur Respir J 2007; 30: Suppl. 51, 364s Year: 2007 Immunomodulatory treatment of severe persistent asthma with interferon-αcon-1 (IFN-αcon-1). Effect on the clinical course of oral corticosteroid dose and eosinophil numbers Source: Annual Congress 2003 - Modulation of bronchial hyperreactivity and immune response in the airways Year: 2003 Omalizumab therapy reduces oral corticosteroid use in patients with severe allergic (IgE-mediated) asthma: European real-life experience Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 Incidence of oropharyngeal candidiasis during treatment with high doses of inhaled corticosteroids Source: Eur Respir J 2002; 20: Suppl. 38, 111s Year: 2002 Retrospective study on the combined use of voriconazole and prednisolone in the treatment of acute allergic bronchopulmonary aspergillosis (ABPA). Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Local side effects of inhaled corticosteroids - incidence of oropharyngeal candidiasis Source: Eur Respir J 2001; 18: Suppl. 33, 266s Year: 2001 Administration of lasolvan in the treatment for exogenic allergic alveolitis (EAA) Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura Year: 2012 A comparison of oral loratadine and fluticasone propionate aqueous nasal spray plus oral loratadine in the treatment of atopic cough associated with seasonal allergic rhinitis (SAR) Source: Eur Respir J 2005; 26: Suppl. 49, 136s Year: 2005 Effect of oral and inhalation corticosteroids on osseous tissue condition for patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 51s Year: 2002 Effect of itraconazole therapy on disease course in 3 cases of allergic bronchopulmonary mycosis presented as refractory asthma Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond Year: 2008 Systemic steroid use in children with allergic (IgE-mediated) asthma receiving omalizumab Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010 Allergic reactions to rifampicin in tuberculosis treatment Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions Year: 2011